Analyst Michael Ryskin of Bank of America Securities reiterated a Sell rating on 10x Genomics (TXG – Research Report), with a price target of $36.00. Michael Ryskin has given his Sell rating due to a ...
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
First fully integrated spatial multiomic assay from 10x Genomics (TXG) brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif ...
July 11 (Reuters) - A federal judge in Delaware said on Monday that 10x Genomics (TXG.O), opens new tab and Harvard University must face antitrust counterclaims over their licensing practices in two ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...
Sept 14 (Reuters) - Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics (TXG.O), opens new tab and Stanford University on Thursday, ...
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results